U.S. Electric Utilities Stock News

NasdaqGS:FRME
NasdaqGS:FRMEBanks

Top Dividend Stocks To Consider In March 2026

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it remains up by 15% over the past year with earnings forecasted to grow by 16% annually. In light of these conditions, selecting dividend stocks that offer consistent payouts and potential for growth can be a strategic approach for investors seeking to balance income and capital appreciation.
NasdaqCM:ASRT
NasdaqCM:ASRTPharmaceuticals

Assessing Assertio Holdings (ASRT) Valuation After 2025 Earnings Results And 2026 Sales Guidance

Earnings report and 2026 outlook come into focus Assertio Holdings (ASRT) has drawn fresh attention after reporting fourth quarter and full year 2025 results that showed lower revenue, a wider net loss, and new 2026 net product sales guidance of US$110.0 million to US$125.0 million. See our latest analysis for Assertio Holdings. The earnings release and 2026 guidance arrived alongside sharp recent gains, with a 30 day share price return of 63.57% and a 1 year total shareholder return of...
NasdaqGS:MGEE
NasdaqGS:MGEEElectric Utilities

Is It Time To Reassess MGE Energy (MGEE) After Its Recent Share Price Weakness?

Wondering whether MGE Energy at around US$75.94 is offering fair value today, or if the price is out of line with the underlying business? This article walks through the key numbers to help you frame that question clearly. The stock has recently moved 2.0% over the last 7 days, while showing an 8.0% decline over 30 days, a 3.2% decline year to date, and a 16.1% decline over the last year, set against gains of 4.7% over 3 years and 18.6% over 5 years. Recent attention around MGE Energy has...
NYSE:AROC
NYSE:AROCEnergy Services

Archrock CFO Transition Puts Capital Allocation And Valuation In Focus

Archrock Inc. (NYSE:AROC) has announced the planned retirement of its long-serving Chief Financial Officer, Douglas S. Aron. The company has begun a formal search process to identify and appoint a new CFO. Aron will continue in his role during the transition period to support continuity in financial leadership. Archrock, a contract compression services provider to the U.S. energy industry, depends heavily on steady capital allocation, balance sheet management and long term contract...
NasdaqGS:ACLX
NasdaqGS:ACLXBiotechs

Is It Too Late To Consider Arcellx (ACLX) After Its Strong 81% YTD Rally?

Wondering if Arcellx at around US$114 per share still offers value, or if the easy money has already been made. The stock has YTD returns of 81.0% and a 1 year return of 68.7%, although the past week has been flat at around a 0.1% decline and the 30 day move sits at 0.8%. Recent coverage has focused on Arcellx as a higher growth biotech name, which helps explain why the share price has been so strong over the past year. That kind of attention often shifts how investors think about both the...
NYSE:HMN
NYSE:HMNInsurance

Undervalued Small Caps With Insider Action Across Regions

Over the last 7 days, the United States market has experienced a 1.6% decline, though it remains up by 15% over the past year with earnings projected to grow by 16% annually. In this context, identifying small-cap stocks that are potentially undervalued and exhibit insider action can offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.
NYSE:KVYO
NYSE:KVYOSoftware

Exploring High Growth Tech Stocks In The US Market March 2026

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has shown resilience with a 15% increase over the past year and expectations for earnings to grow by 16% annually in the coming years. In this context of fluctuating short-term performance but promising long-term growth prospects, identifying high growth tech stocks that can capitalize on these trends becomes essential for investors seeking potential opportunities.
NYSE:VLO
NYSE:VLOOil and Gas

US Stock Market Today S&P 500 Futures Steady As Inflation And Geopolitical Risks Persist

The Morning Bull - US Market Morning Update Friday, Mar, 27 2026 US stock futures are mixed this morning, with S&P 500 contracts hovering near flat as investors weigh higher borrowing costs against hotter inflation and geopolitical risk. The US 10 year Treasury yield is holding around 4.41%, which keeps pressure on everything from credit cards to business loans, while the average 30 year mortgage rate sits at 6.38%, keeping home buying more expensive. At the same time, Middle East tensions...
NasdaqGM:SIGA
NasdaqGM:SIGAPharmaceuticals

SIGA Technologies Special Dividend Highlights Capital Return And Profit Pressures

SIGA Technologies (NasdaqGM:SIGA) has declared a special cash dividend for its shareholders. The announcement provides a direct cash return in addition to any regular dividend policy the company may have. The timing of the dividend decision highlights management's current view of the company’s cash position and capital needs. SIGA Technologies focuses on health security solutions, including products designed for infectious disease and biodefense settings. A special cash dividend draws...
NasdaqGS:RBCA.A
NasdaqGS:RBCA.ABanks

Republic Bancorp Joins S&P Index With Apparent Valuation Upside

Republic Bancorp, Inc. (NasdaqGS:RBCA.A) has been added to the S&P Regional Banks Select Industry Index. The inclusion places the company alongside a peer group of publicly traded regional banks tracked by institutional and index investors. Republic Bancorp operates as a regional banking company, with its core business centered on traditional lending, deposits, and related financial services. Inclusion in the S&P Regional Banks Select Industry Index can draw more attention from...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Bio Techne Spatial Biology Expansion And What It Could Mean For Valuation

Bio-Techne, ticker NasdaqGS:TECH, has expanded its COMET spatial biology workflow with new SPYRE Focus Panels and Amplification Kits. The company has also released upgrades to its HORIZON Image Analysis Software to support more advanced tissue analysis. The updates aim to give researchers greater flexibility, sensitivity, and throughput in preclinical and translational studies. Bio-Techne is adding this product expansion at a time when the share price is around $52.70, with the stock down...
NasdaqGS:ADEA
NasdaqGS:ADEASoftware

Is It Too Late To Consider Adeia (ADEA) After Its 77% One Year Rally?

If you are wondering whether Adeia's share price still reflects fair value after its recent run, this breakdown will help you separate price from worth. The stock last closed at US$24.36, with returns of 3.9% over 7 days, 23.3% over 30 days, 38.6% year to date and 76.7% over the past year, providing context for any valuation check. Recent coverage has focused on Adeia's role as a software company and the way investors are reacting to its business model and positioning. This backdrop helps...
NYSE:PAG
NYSE:PAGSpecialty Retail

Penske Sale Of Lexus Of Warwick Signals Ongoing Portfolio Reset

Penske Automotive Group (NYSE:PAG) has completed the sale of Lexus of Warwick in Rhode Island. The buyer is the McGee Automotive Family, which plans to continue operating the dealership as a Lexus store. The transaction marks a change in Penske Automotive Group's dealer portfolio and geographic mix. Penske Automotive Group (NYSE:PAG) is a diversified transportation services company with a large network of franchised dealerships. The sale of Lexus of Warwick fits into a broader pattern of...
NasdaqCM:WYFI
NasdaqCM:WYFIIT

WhiteFiber (WYFI) Q3 Loss Of US$15.8 Million Tests Bullish Profitability Narrative

WhiteFiber (NasdaqCM:WYFI) has posted its FY 2025 results with Q3 revenue of about US$20.2 million and a basic EPS loss of US$0.47, set against trailing twelve month revenue of roughly US$70.2 million and a net loss of US$24.2 million. Over the past several quarters, the company has seen revenue move from US$12.3 million in Q3 FY 2024 to US$20.2 million in Q3 FY 2025, while quarterly net income has swung between a profit of US$1.4 million in Q1 FY 2025 and a loss of US$15.8 million in Q3 FY...
NasdaqGS:MGTX
NasdaqGS:MGTXBiotechs

MeiraGTx Holdings (MGTX) Q3 Loss Of US$50.5m Reinforces Bearish Community Narratives

MeiraGTx Holdings (MGTX) just posted its FY 2025 third quarter numbers, with revenue at US$0.4 million and a basic EPS loss of US$0.62, alongside net income excluding extra items of a US$50.5 million loss. Over recent quarters, the company has seen revenue move from US$21.4 million in Q4 2024 to US$3.7 million in Q2 2025, while quarterly basic EPS has tracked between a loss of US$0.48 and US$0.76. This sets the backdrop for the current trailing twelve month loss of US$168.7 million on US$27.4...